Skip to main content
BDX
NYSE Industrial Applications And Services

BD Recasts Historical Financials Post-Spin-Off for Continuing Operations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$154.51
Mkt Cap
$43.995B
52W Low
$127.536
52W High
$187.35
52W Position info
21% above low
Off High info
18% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BDX sits 21% above its 52-week low of $127.536.

Summary

Becton Dickinson provides recast historical financial data, presenting its spun-off business as discontinued operations to establish a clear financial baseline for its continuing business.


Key Events · Corporate Governance and Compliance · BDX

  • Recast Historical Financials

    Becton Dickinson furnished unaudited recast historical financial information, reflecting the Biosciences and Diagnostic Solutions business as discontinued operations.

  • Post-Spin-Off Baseline

    This re-presentation provides a historical baseline of BD's standalone operating results from continuing operations, excluding specified items, following the February 9, 2026 spin-off.

  • Non-GAAP Measures Included

    The furnished exhibit includes certain non-GAAP financial measures with adjustments for purchase accounting, integration, restructuring, transaction costs, and other items to aid in period-over-period comparability.


Analysis · BDX · Industrial Applications And Services

Becton Dickinson has filed recast historical financial information to reflect its Biosciences and Diagnostic Solutions business as discontinued operations following the spin-off on February 9, 2026. This filing is crucial for investors and analysts to establish a new financial baseline for BD's continuing operations, enabling accurate year-over-year comparisons and future performance analysis. It provides transparency into the company's standalone financial health post-separation.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDX was trading at $154.51 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $44B. The 52-week trading range was $127.54 to $187.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Aug 06, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $177.07
Real-time Price: $176.80 info
Change: -$0.270 (-0.15%) info
Market Cap: $48.158B info
BDX
Aug 06, 2026, 6:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $176.80 info
Change: +$4.80 (+3%) info
Market Cap: $48.158B info
BDX
Aug 06, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $172.00
Real-time Price: $176.80 info
Change: +$4.80 (+3%) info
Market Cap: $48.158B info
BDX
Jul 31, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.42
Real-time Price: $176.80 info
Change: +$11.39 (+7%) info
Market Cap: $48.158B info
BDX
Jul 29, 2026, 6:54 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $161.25
Real-time Price: $176.80 info
Change: +$15.55 (+10%) info
Market Cap: $48.158B info